Today: September 26, 2016, 2:14 am

Global bioinformatics IVD testing market: New market research published
Bioinformatics in IVD Testing - a new market research report on 2014-03-14 17:05:02
This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact.What developments are driving this trend? What are labs and providers doing to incorporate these products into practice? And how are payors and regulators reacting? Who is partnering with who to deliver a solid combination product? This report delves into these issues and provides an excellent round-up of the current status of bioinformatics in the IVD industry.As part of its coverage, the report provides information on the following developments:- Selected Diagnostic Tests That Incorporate Bioinformatics
- Selected Multiplexed Tissue-Based Cancer Tests
- Selected Histology Analyses Software Tools
- Selected Blood-Based Cancer Biomarker Tests That Use Software Analysis Tools
- Selected Chronic Diseases Tests With Integrated Bioinformatics
- Selected Innovations in Bioinformatic-Based Tests For Psychiatric Disorders
- Selected Systems For Bioinformatics-Based Infectious Disease Testing
- Selected Next Generation Sequencing PlatformsThe report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Many of the assays and techniques presented in the report are expected to replace the standard of care in 2013, but with healthcare systems´ emphasis on cost/benefit analysis for new technologies adoption, the market value and thus penetration capabilities of newer approaches may be limited.The report looks at the bioinformatics-based product offerings and developments of the following companies, among others:- Abbott
- Cannon
- RocheAffymetrix Inc.
- AssureRx Health, Inc.
- Bio-Reference Laboratories, Inc. (BRLI)
- Dako A/S
- Siemens
- Thermo Fisher
- Medtronic Inc.
- PerkinElmer, Inc.
- Prometheus Labs
- Quest

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 492 Words
Related Articles
More From Finance
P2P lending platform Monexo partners with IDBI-Trusteeship [..]
For Immediate Release: 2nd September 2016 MUKESH BUBNA, CEO Monexo Fintech Pvt Limited P2P [..]
Day Trade to Win New September Class [..]
Sold Out? New Class Added – On September 6, 2016, is launching a brand new eight-week trading boot camp [..]
FTM (Forget The Market) Reopens 3 Shares [..]
Port Vila, Vanuatu, 28th July 2016 - Investment firm FTM today announced the reopening of three separate share options, projected [..]
Ex-Citibanker Launching Online P2P marketplace in India [..]
A study conducted by World Bank shows that MSMEs in India face an estimated credit gap of INR 20.9 trillion [..]
New Frontier Portfolios Top Morningstar Rankings
New Frontier’s global strategic portfolios topped the Global Balanced Strategic/All-Inclusive category of the latest Morningstar ETF [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.